IgE and eosinophil count at 6 years old predicts long-term risk of ABPA in children with CF. - Vienna 2024

General characteristics of cystic fibrosis and impact of cystic fibrosis transmembrane conductance regulator modulators on the disease

Chair(s): B?lent Taner Karadag, Lucy Perrem

Session type: Oral presentation

IgE and eosinophil count at 6 years old predicts long-term risk of ABPA in children with CF.

Harriet Crabtree

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Chest magnetic resonance as an alternative imaging examination for follow-up of patients with cystic fibrosis

Gabriela Gama Martins

Replay

Poster

Abstract

Slides

A 10-year cost trajectory study in children with cystic fibrosis in France

Philippe Reix

Replay

Poster

Abstract

Slides

Home insulation and mold exposure: assessing their influence on lung function in people with cystic fibrosis

Ceren Ay?a Yildiz

Replay

Poster

Abstract

Slides

IgE and eosinophil count at 6 years old predicts long-term risk of ABPA in children with CF.

Harriet Crabtree

Replay

Poster

Abstract

Slides

Real-life effect of elexacaftor/tezacaftor/ivacaftor therapy on microbiological findings in patients with Cystic fibrosis

Francesca Lucca

Replay

Poster

Abstract

Slides

Efficacy of Elaxacaftor/Tezacaftor/Ivacaftor after market authorization in pwCF

Andreas Jung

Replay

Poster

Abstract

Slides

Long-term outcomes in people with CF lacking early spirometry response to elexacaftor/tezacaftor/ivacaftor therapy

Mohamad Hadhud

Replay

Poster

Abstract

Slides

Health implication of the COVID-19 pandemic for children with Cystic Fibrosis (CF) followed at CF center Copenhagen

Marika Nathalie Schmidt

Replay

Poster

Abstract

Slides

Thermal and mechanical pain thresholds in children and young adults with cystic fibrosis and primary ciliary dyskinesia

Stefanie Dillenh?fer

Replay

Poster

Abstract

Slides

The impact of tracheobronchomalacia on lung disease, microbiology and inflammation in children with cystic fibrosis

Julie Depiazzi

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}